Reactive oxygen species generated by hematopoietic cytokines play roles in activation of receptor-mediated signaling and in cell cycle progression

被引:86
作者
Iiyama, M [1 ]
Kakihana, K [1 ]
Kurosu, T [1 ]
Miura, O [1 ]
机构
[1] Tokyo Med & Dent Univ, Dept Hematol, Bunkyo Ku, Tokyo 1138519, Japan
关键词
ROS; IL-3; erythropoietin; Jak2; STAT5; Akt; c-Myc;
D O I
10.1016/j.cellsig.2005.04.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Hematopoietic cytokines, including interleukin (IL)-3 and erythropoietin (Epo), regulate hematopoiesis by stimulating their receptors coupled with the Jak2 tyrosine kinase to induce receptor tyrosine phosphorylation and activate mainly the STAT5, PI3K/Akt, and Ras/MEK/ERK signaling pathways. Here we demonstrate that IL-3 or Epo induces a rapid and transient (peaking at 30 min) as well as late progressive increase in reactive oxygen species (ROS) in a hematopoietic progenitor model cell line, 321363, and its subclone expressing the Epo receptor (EpoR), 32D/EpoR-Wt. The cytokine-induced ROS generation was not affected in 32Dcl3 cells depleted of mitochondrial DNA. The antioxidant N-acetyl-L-cysteine (NAC) inhibited IL-3-induced tyrosine phosphorylation of Jak2, IL-3 receptor Pc subunit (IL-3R beta c), and STAT5 as well as activation-specific phosphorylation of Akt, MEK, and ERK, while treatment of cells with H(2)O(2) activated these signaling events. NAC also inhibited the EpoR-induced transphosphorylation of IL-3Rpc. Moreover, NAC treatment reduced the expression levels of c-Myc, Cyclin D2, and Cyclin E, and induced expression of p27, thus inhibiting the G1 to S phase transition of cells cultured with IL-3. Further studies have shown that the degradation of c-Myc was facilitated or inhibited by treatment of cells with NAC or H(2)O(2), respectively. These data indicate that the rapid generation of ROS by cytokine stimulation, which is at least partly independent of mitochondria, may play a role in activation of Jak2 and the STAT5, PI3K/Akt, and Ras/MEK/ERK signaling pathways as well as in transactivation of cytokine receptors. The cytokine-induced ROS generation was also implicated in G1 to S progression, possibly through stabilization of c-Myc and induction of G1 phase Cyclin expression leading to suppression of p27. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:174 / 182
页数:9
相关论文
共 33 条
[1]   Fyn and JAK2 mediate Ras activation by reactive oxygen species [J].
Abe, J ;
Berk, BC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (30) :21003-21010
[2]   Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway [J].
Arai, A ;
Kanda, E ;
Miura, O .
ONCOGENE, 2002, 21 (17) :2641-2651
[3]   Platelet-derived growth factor-induced H2O2 production requires the activation of phosphatidylinositol 3-kinase [J].
Bae, YS ;
Sung, JY ;
Kim, OS ;
Kim, YJ ;
Hur, KC ;
Kazlauskas, A ;
Rhee, SG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) :10527-10531
[4]   Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells [J].
Boonstra, J ;
Post, JA .
GENE, 2004, 337 :1-13
[5]   Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 [J].
Bouchard, C ;
Thieke, K ;
Maier, A ;
Saffrich, R ;
Hanley-Hyde, J ;
Ansorge, W ;
Reed, S ;
Sicinski, P ;
Bartek, J ;
Eilers, M .
EMBO JOURNAL, 1999, 18 (19) :5321-5333
[6]   Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction [J].
Chiarugi, P ;
Cirri, P .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (09) :509-514
[7]   Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (beta(IL3)) and recruitment of Stat5 to possible Stat5-docking sites in beta(IL3) [J].
Chin, H ;
Wakao, H ;
Miyajima, A ;
Kamiyama, R ;
Miyasaka, N ;
Miura, O .
BLOOD, 1997, 89 (12) :4327-4336
[8]   Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies [J].
Clarkson, B ;
Strife, A ;
Wisniewski, D ;
Lambek, CL ;
Liu, C .
LEUKEMIA, 2003, 17 (07) :1211-1262
[9]   The erythropoietin receptor: Structure, activation and intracellular signal transduction [J].
Constantinescu, SN ;
Ghaffari, S ;
Lodish, HF .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (01) :18-23
[10]  
Cunnick JM, 1998, BIOCHEM MOL BIOL INT, V45, P887